TOBI Podhaler · DIN 02365154 · 28 mg · Inh Pd-capsule
Limited Use, Reason for Use code 472 requiredMarketed · checked November 18, 2026
StatusLimited Use, Reason for Use code 472 required
Write on scriptReason for Use code 472 (criteria below)
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays:
• ODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
• Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 472
Reason for Use code 472
For the management of cystic fibrosis patients with chronic pulmonary Pseudomonas aeruginosa (P. aeruginosa) infections.
Tobramycin is administered in alternating periods of 28 days. After 28 days of therapy, patients should stop therapy for the next 28 days, and then resume therapy for the next 28 day on / 28 day off cycle.
Coverage limit:
LU Authorization Period: Indefinite
No interchangeable product listed in the Ontario extract
TOBI Podhaler · DIN 02365154
Manufacturer: BGP Pharma ULC; listing date 2016-06-29
Health Canada: Marketed since 2020-03-11 · brand TOBI PODHALER · ATC J01GB01 TOBRAMYCIN · form Capsule · route Inhalation · ingredients TOBRAMYCIN 28 MG · company Bgp pharma ulc · schedule Prescription
TOBI Podhaler: Formulary list price $14.69 per unit (the source does not state the unit; exact figure $14.6911). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02365154)
Source record
DIN 02365154: TOBI Podhaler
Raw flags: sec12=Y, sec3=Y
Item: 081228163; group id 50; item number 0107; lccId 00265; manufacturer id BGP
Source form: Inh Pd-Cap; strength: 28mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $14.6911; ministry $14.6911
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02365154
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=85000
Shortage status: not checked (no credentials)